BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6178827)

  • 1. An evaluation of two antigen nonspecific assays for circulating immune complexes using a model system.
    Rodrick M; Rayner A; Steele G; Harte P; Finn D; Verhave M; Munroe A; Zamcheck N; Wilson R
    J Clin Lab Immunol; 1982 Apr; 7(3):193-8. PubMed ID: 6178827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes and rheumatoid arthritis: the induction of immune complex formation between rheumatoid factor and IgG by polyethylene glycol.
    Faaber P; van den Bersselaar LA; van de Putte L; van den Berg WB
    J Rheumatol; 1989 Oct; 16(10):1304-9. PubMed ID: 2681758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
    Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
    J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of immune complexes by a new assay, the polyethylene glycol precipitation-complement consumption test (PEG-CC).
    Harkiss GD; Brown DL
    Clin Exp Immunol; 1979 Apr; 36(1):117-29. PubMed ID: 111880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and quantitation of immune complexes by polyethylene glycol-laser nephelometer assay. I. Immunological study in chronic serum sickness in rabbits.
    Mikulska B; Krajewski S; Madaliński K
    Arch Immunol Ther Exp (Warsz); 1983; 31(2):109-20. PubMed ID: 6418113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.
    Bruneau C; Bonin H
    Clin Exp Immunol; 1983 Sep; 53(3):529-35. PubMed ID: 6616954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of sera from ovarian cancer patients for immune complexes.
    Witkin SS; Bongiovanni AM; Armbruster T; Birnbaum S; Caputo T
    J Clin Lab Immunol; 1984 Jun; 14(2):65-8. PubMed ID: 6748047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of circulating immune complexes in leprosy.
    Ramos GS; Bottasso OA; Morini JC; Segal-Eiras A
    Rev Argent Microbiol; 1988; 20(4):163-70. PubMed ID: 3247413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of circulating immune complexes in pulmonary tuberculosis.
    Samuel AM; Ashtekar MD; Ganatra RD
    Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes.
    Valentijn RM; van Es LA; Daha MR
    J Clin Lab Immunol; 1984 Jun; 14(2):81-6. PubMed ID: 6748050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circulating immune complexes in the serum in Hodgkin's disease].
    Nikolić V; Zivanović L; Banićević B; Milosević-Jovcić N
    Bilt Hematol Transfuz; 1980; 8(1):19-27. PubMed ID: 7337679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The detection of circulating immune complexes containing immunoglobulin G.
    Valentijn RM; van Es LA; Westedt ML; Daha MR
    J Clin Lab Immunol; 1984 Jun; 14(2):73-9. PubMed ID: 6748049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the PEG-IgG screening test for soluble immune complexes by longitudinal studies in experimental acute serum sickness.
    Kilpatrick JM; Pitt A; Ainsworth SK; Virella G
    J Clin Lab Immunol; 1985 Jun; 17(2):79-84. PubMed ID: 4045998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of complement component C5 to model immune complexes and the use of anti-C5 antibodies for determination of C5-containing circulating immune complexes.
    Larsson A; Sjöquist J
    J Clin Lab Immunol; 1989 Jan; 28(1):5-9. PubMed ID: 2724329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
    Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
    Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes in rheumatoid arthritis: a prospective study using five immunoassays.
    Reynolds WJ; Yoon SJ; Emin M; Chapman KR; Klein MH
    J Rheumatol; 1986 Aug; 13(4):700-6. PubMed ID: 3490573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical analyses of components of immune complexes in the sera of patients with autoimmune diseases.
    Ferraccioli G; Karsh J; Osterland CK
    J Rheumatol; 1983 Dec; 10(6):881-8. PubMed ID: 6663592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple, rapid and sensitive assay for immune complexes using a Staphylococcus aureus immunoadsorbent.
    Barkas T
    J Clin Lab Immunol; 1981 Jan; 5(1):59-65. PubMed ID: 7012354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avidity of antibodies to dsDNA: comparison of IFT on Crithidia luciliae, Farr assay, and PEG assay.
    Smeenk R; van der Lelij G; Aarden L
    J Immunol; 1982 Jan; 128(1):73-8. PubMed ID: 7033379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.